ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
China tech

'Huawei of genomics' plots global expansion on COVID windfall

Threat of US sanctions clouds outlook for China's BGI

A BGI genetic testing laboratory in Kunming: The company looks to parlay global connections forged through the COVID testing labs to expand its genomics business worldwide.   © Reuters

GUANGZHOU -- Just days after Guangzhou reported a surge in coronavirus cases at the end of May, a massive PCR testing lab appeared seemingly out of thin air at a gymnasium in the southern Chinese city.

First appearing in Wuhan during February 2020 at the beginning of the pandemic, the inflatable Huo-Yan lab developed by Chinese genomics company BGI Group has been used in over 30 countries and regions.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more